He was vice president of research and operations at Stratagene ( now Agilent Technologies ) , president of the Stratagene antibody subsidiary Stratacyte , then founder and CEO of Diversa until 2005 .
Jay M. Short is founder and CEO of the antibody drug company BioAtla , LLC .
Jay M. Short was founder   of research and operations at Stratagene ( now Agilent Technologies ) , president of the Stratagene antibody subsidiary Stratacyte , then founder and CEO of Diversa until 2005 .
Jay M. Short is founder and CEO of the antibody drug company BioAtla , LLC .